Health Care Checkup

July 25, 2025

THE BIG PICTURE: KEY CONGRESSIONAL & EXECUTIVE BRANCH DEVELOPMENTS


On Wednesday, the House Energy and Commerce Committee held a markup advancing the Over-the-Counter Monograph Drug User Fee Amendments (H.R. 4273), reauthorizing the Food and Drug Administration's over-the-counter drug user fee program in a unanimous 51-0 vote.


On Thursday, the Health, Education, Labor and Pensions (HELP) Committee advanced Brian Christine’s nomination to be Assistant Secretary of Health and Human Services in a 12-11 party-line vote.

What to Expect Next Week:



The Senate could vote to confirm Susan Monarez to lead the CDC as early as next week. On Thursday, Senate Majority Leader John Thune (R-SD) filed to limit debate on her nomination, teeing up a floor vote.


The Senate Health, Education, Labor, and Pensions (HELP) Committee will mark up seven healthcare and labor bills on Wednesday. The HELP Committee will also hold a hearing on affordable healthcare on Thursday.


The House is in recess and will return to session on Tuesday, September 2.

DEEP DIVE

Congressional:


House Energy & Commerce Committee Advances Over-the-Counter Monograph Drug User Fee Amendments Bill in Markup

On Wednesday, the House Energy and Commerce Committee held a markup on two bills, including one healthcare bill, the Over-the-Counter Monograph Drug User Fee Amendments (H.R. 4273). The committee voted to advance the bill reauthorizing the Food and Drug Administration's over-the-counter drug user fee program in a unanimous 51-0 vote. The 2020 COVID-19 relief law (PL 116-136) authorized the FDA to collect user fees from companies to support its oversight of over-the-counter monograph drugs through a provision within that legislation. That authority will expire on September 30 if Congress does not act.


Senate HELP Committee Advances HHS Assistant Secretary Nomination

On Thursday, the Health, Education, Labor and Pensions (HELP) Committee advanced Brian Christine’s nomination to be Assistant Secretary of Health and Human Services in a 12-11 party-line vote. During a confirmation hearing last week, Christine expressed support for the MAHA agenda and called himself a "Main Street doctor," citing his experience working directly with patients. Chairman Bill Cassidy said in a statement following the vote that, "These nominees are vital to advancing President Trump's pro-worker, pro-family, pro-patient agenda."


House Energy and Commerce Committee Holds Hearing on U.S. Organ Procurement & Transplant System

On Tuesday, the House Energy and Commerce Oversight and Investigations Subcommittee held a hearing to examine concerns about the U.S. organ procurement and transplant system after a federal investigation raised serious questions about patient safety and oversight. During the hearing, members questioned leaders from the Kentucky-based Network for Hope (KYDA) and the United Network for Organ Sharing (UNOS) following a Health Resources and Services Administration (HRSA) report that found organs had been taken from more than two dozen patients who may not have been definitively deceased, with some showing signs of life. Subcommittee Chair John Joyce (R-PA) stated the findings “fractured the physician-patient relationship” and demanded accountability from the KYDA and UNOS. Witness, Dr. Raymond Lynch, who leads HRSA’s Organ Transplant Branch, told lawmakers the issues are not isolated, stating, “Unfortunately, it is not limited to [Network for Hope].” Members also raised concerns about racial bias and retaliation against whistleblowers, with UNOS CEO Maureen McBride and Network for Hope CEO Barry Massa both facing questions about their organizations’ practices. Massa defended his KYDA’s procedures but acknowledged communication failures. The hearing took place a day after the Department of Health and Human Services (HHS) announced increased oversight of the transplant system and warned that programs could be decertified if they fail to correct deficiencies, emphasizing that the dignity of every potential donor must be protected. Read Mehlman’s hearing summary here.


Representatives Smith, Schweikert Demand Organ Procurement Organizations Turn Over Records as Part of Committee Investigation  

On Wednesday, Ways and Means Committee Chairman Jason Smith (R-MO) and Oversight Subcommittee Chairman David Schweikert (R-AZ) demanded that three Organ Procurement Organizations (OPOs) provide the Committee with financial records, information related to the use of private jets, and other documents following allegations of potential Medicare reimbursement fraud and abuse. The letters to the OPOs follow a public call for information in April 2025, as part of the Committee’s examination into whether these tax-exempt organizations are abiding by the existing laws and regulations. Read the press release and letters here.


House Ways and Means Health and Oversight Subcommittees Hold Hearing on Medicare Advantage

On Tuesday, the House Ways and Means Health and Oversight Subcommittees held a joint hearing to examine Medicare Advantage (MA). During the hearing, most witnesses and members from both parties agreed that while MA is valuable, it requires improvements to ensure sustainability and better value for beneficiaries and taxpayers. Members expressed bipartisan support to address overpayments, upcoding, and unnecessary and excessive use of prior authorization in the program. Health Subcommittee Chair Vern Buchanan (R-FL) and Oversight Subcommittee Chair David Schweikert (R-AZ) both expressed interest in using technology and innovation to improve care coordination and reduce costs, emphasizing the need for a proactive approach. Read Mehlman’s hearing summary here.

 

Wyden, Warner Sound the Alarm on Hospital Cybersecurity Risks Following Passage of GOP’s OBBBA

On Monday, Senate Finance Committee Ranking Member Ron Wyden (D-OR) and Senator Mark Warner (D-VA) called on the Trump administration to share its plan for preventing cyberattacks on rural hospitals. The letter, sent to Department of Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. and Centers for Medicare & Medicaid Services (CMS) Administrator Mehmet Oz, calls on the Administration to share its plans to help small and rural hospitals meet federal cybersecurity standards, as well as its plan to use the rural health transformation program to fund cybersecurity improvements. Wyden and Warner wrote in the letter that “As rural and small hospitals confront even lower operating margins due to Republican health care cuts, they will be less likely to prioritize spending on cybersecurity infrastructure. The lack of federal oversight and resources, coupled with historic cuts to Medicaid and the ACA, only serve to increase rural and small hospitals’ cybersecurity vulnerabilities.” Read the press release and letter here.


CBO Releases New Estimate of Changes to Uninsured from One Big Beautiful Bill

On Monday, the Congressional Budget Office (CBO) released an updated estimated budgetary effect of the One Big Beautiful Bill Act (PL 119-21), which passed into law on July 4. The CBO estimated that the law will result in 10 million people losing health insurance over the next 10 years. The uninsured number is lower than the CBO's initial estimate on the Senate's version of the bill, which it said would have led to about 11.8 million losing health insurance. The decrease is largely due to the Senate parliamentarian striking a provision in the Senate version that would have lowered the Federal Matching Assistance Program (FMAP) for states that provided coverage to undocumented immigrants. The CBO examined the law's changes to coverage eligibility and other provisions, estimating that some beneficiaries who lose Medicaid coverage will obtain coverage through private insurance from their employer. The CBO also estimated that the law will have a net effect on the deficit of $3.394 trillion between 2025 and 2034 compared to the January 2025 baseline. Read the report here. 


Notable Bills Introduced:


Senators Boozman, Warnock, Collins, Schumer Lead Push to Boost Supply of Doctors, Ensure Access to Medical Care

On Thursday, Senator John Boozman (R-AR), along with Senators Raphael Warnock (D-GA), Susan Collins (R-ME), and Minority Leader Chuck Schumer (D-NY), introduced the bipartisan Resident Physician Shortage Reduction Act to increase the number of Medicare-supported doctor training slots available for medical students and address the shortage of primary and specialty care physicians. The legislation would raise the number of residency program positions that Medicare can fund by 14,000 over seven years. Read the press release here and the bill here.

 

Senators Thune, Warner Reintroduce Legislation to Expand Seniors' Options for Care

On Thursday, Senators John Thune (R-SD) and Mark Warner (D-VA) reintroduced the Equitable Community Access to Pharmacist Services (ECAPS) Act. The bill would allow Medicare to reimburse for certain pharmacist-administered tests, treatments, and vaccinations for illnesses like influenza, respiratory syncytial virus (RSV), and strep throat, in accordance with state scope-of-practice laws. Read the press release here and the bill here.

 

Senators Klobuchar, Lee, Durbin, Grassley Introduce Bipartisan Legislation to Increase Competition and Lower Prescription Drug Prices for Consumers

On Wednesday, Senators Amy Klobuchar (D-MN), Mike Lee (R-UT), Dick Durbin (D-IL), and Chuck Grassley (R-IA) reintroduced legislation aimed at increasing competition in the pharmaceutical industry and lowering prices for consumers. The Short on Competition Act would allow the Secretary of Health and Human Services (HHS) to grant expedited reviews and inspections, and temporary importation when there is, or is likely to be, a prescription drug shortage or when there are fewer than five competitors in a market for prescription drugs that have been approved for at least 10 years. Read the press release here and the bill here.

 

Representative Murphy Introduces Bipartisan, Bicameral Legislation to Improve Enforcement of No Surprises Act

On Wednesday, Representative Greg Murphy, M.D. (R-NC), introduced the No Surprises Enforcement Act, alongside Representatives Jimmy Panetta (D-CA), John Joyce, M.D. (R-PA), Raul Ruiz, M.D. (D-CA), Bob Onder, M.D. (R-MO), and Kim Schrier, M.D. (D-WA), to reinforce the historic No Surprises Act, which protects patients from surprise medical bills. Specifically, the No Surprises Act Enforcement Act will reinforce the original intent of the No Surprises Act by closing enforcement gaps through increasing penalties for parties who are non-compliant with payment deadlines. The bill also increases transparency in reporting requirements. Senators Roger Marshall, M.D. (R-KS), and Michael Bennet (D-CO) introduced companion legislation in the United States Senate. Read the press release here and the bill here.

 

Representative Matsui & Senator Welch Reintroduce Legislation to Protect 340B Drug Pricing Program

On Tuesday, Representatives Doris Matsui (D-CA) and Senator Peter Welch (D-VT) introduced the 340B PATIENTS Act, legislation that would protect and strengthen the 340B program by codifying 340B providers’ ability to use contract pharmacies to dispense 340B discounted drugs. This would ensure that 340B patients can pick up their prescriptions at any local pharmacy and that safety-net providers can continue to provide expanded medical and social services to their communities using their 340B discount savings. Read the press release here and the bill here.

 

Representatives Doggett, Murphy Introduce Bipartisan Bill to Ensure Adequate Provider Payments under Medicare Advantage

On Tuesday, Representatives Lloyd Doggett (D-TX), Ranking Member of the Ways and Means Health Subcommittee, and Health Subcommittee member Greg Murphy, M.D. (R-NC) introduced bipartisan legislation to set payment rates and timelines for Medicare Advantage (MA) plans.. The Prompt and Fair Pay Act establishes a floor requiring MA plans to reimburse for all covered health care items and services at least what would have been paid under Medicare Parts A and B; plans and providers may continue to negotiate higher reimbursement rates. The legislation also establishes prompt payment rules for clean in-network claims, which are requirements that would mirror those under Medicare Part D. Read the press release here and the bill here. 

 

Executive Branch:


HHS Adopts ACIP Recommendation to Remove Thimerosal from all U.S. Influenza Vaccines

On Wednesday, Health and Human Services Secretary Robert F. Kennedy, Jr. adopted recommendations from the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) to remove the mercury-based preservative thimerosal from all influenza vaccines distributed in the United States. Vaccine makers removed thimerosal from roughly 95 percent of flu vaccinations in 1999 following unfounded claims about mercury that eroded some public trust in immunizations. The ingredient is a preservative used in some multi-dose batches of vaccines. Kennedy adopted the recommendations in the absence of a Senate-confirmed director of the Centers for Disease Control and Prevention. The Senate Health, Education, Labor and Pensions Committee advanced the nomination of Susan Monarez to lead the agency earlier this month, but she has yet to receive a confirmation vote in the full Senate. Read the press release here.

 

HHS Finds Systemic Disregard for Sanctity of Life in Organ Transplant System

On Monday, the Department of Health and Human Services (HHS), under the leadership of Secretary Robert F. Kennedy, Jr., announced a major initiative to begin reforming the organ transplant system following an investigation by its Health Resources and Services Administration (HRSA). HRSA directed the Organ Procurement and Transplantation Network (OPTN) to reopen a case involving potentially preventable harm to a neurologically injured patient by the federally-funded organ procurement organization (OPO) serving Kentucky, southwest Ohio, and part of West Virginia. HRSA examined 351 cases where organ donation was authorized, but ultimately not completed, finding 73 patients had neurological signs incompatible with organ donation, and at least 28 patients may not have been deceased at the time organ procurement was initiated. In response to these findings, HRSA has mandated strict corrective actions for the OPO and system-level changes to safeguard potential organ donors nationally. The OPO must conduct a full root cause analysis of its failure to follow internal protocol, including noncompliance with the five-minute observation rule after the patient’s death, and develop clear, enforceable policies to define donor eligibility criteria. Additionally, it must adopt a formal procedure allowing any staff member to halt a donation process if patient safety concerns arise. Secretary Kennedy stated that he will decertify the OPO if it fails to comply with these corrective action requirements. Read the press release here.

 

Makary Names Biotech Veteran George Tidmarsh to Lead FDA's Centers for Drug Evaluation and Research

On Monday, Food and Drug Administration (FDA) Commissioner Marty Makary appointed George Francis Tidmarsh, a pediatric specialist and biopharma business founder, to lead the Centers for Drug Evaluation and Research. Tidmarsh founded and served as CEO of multiple biopharma companies that focused on oncology and critical care medicine, according to his LinkedIn bio. He also serves as an adjunct professor of pediatrics and neonatology at Stanford University School of Medicine. He received his M.D. and Ph.D. from Stanford and completed his residency in pediatrics at the university. The announcement follows the retirement of acting director Jacqueline Corrigan-Curay, who announced her departure last month. Makary said in a statement, "Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development -- from bench to bedside." Read the press release here. 

CONGRESSIONAL HEARINGS & EVENTS

House:

 

The House is in recess and will return to session on Tuesday, September 2. 

 

Senate:

 

Senate Health, Education, Labor, and Pensions Committee – Markup

“To consider S.2292, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, S.1440, to amend title II of the Public Health Service Act to include as an additional right or privilege of commissioned officers of the Public Health Service (and their beneficiaries) certain leave provided under title 10, United States Code to commissioned officers of the Army (or their beneficiaries), S.2301, to reauthorize certain programs regarding rural health care, S.1727, to amend the Employee Retirement Income Security Act of 1974 to permit employee stock ownership plan participants to benefit from the full amount of beneficial ownership that can be accrued in the plan while also fully realizing the benefits of saving for retirement in a defined contribution plan, S.1728, to amend the Employee Retirement Income Security Act of 1974 to expand the membership of the Advisory Council on Employee Welfare and Pension Benefit Plans to include representatives of employee ownership organizations, an original bill entitled "Kay Hagan Tick Reauthorization Act", and an original bill entitled "Retire Through Ownership Act".

Wednesday, July 30, at 10:00 AM

 

Senate Health, Education, Labor, and Pensions Committee – Hearing

“To examine making health care affordable, focusing on solutions to lower costs and empower patients.”

Thursday, July 31, at 10:00 AM

ADMINISTRATION ANNOUNCEMENTS

Centers for Medicare & Medicaid Services

Food and Drug Administration

National Institutes of Health

1341 G Street NW
Washington, DC 20005
202-585-0258